• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Identification and mapping of neutralizing epitopes of human parvovirus B19 by using human antibodies.利用人源抗体鉴定和绘制人细小病毒B19的中和表位
J Virol. 1991 Oct;65(10):5485-90. doi: 10.1128/JVI.65.10.5485-5490.1991.
2
Identification of the region including the epitope for a monoclonal antibody which can neutralize human parvovirus B19.鉴定包含可中和人细小病毒B19的单克隆抗体表位的区域。
J Virol. 1991 Apr;65(4):1667-72. doi: 10.1128/JVI.65.4.1667-1672.1991.
3
Neutralizing linear epitopes of B19 parvovirus cluster in the VP1 unique and VP1-VP2 junction regions.B19细小病毒的中和线性表位聚集在VP1独特区和VP1-VP2连接区。
J Virol. 1993 Jun;67(6):3004-9. doi: 10.1128/JVI.67.6.3004-3009.1993.
4
Fine mapping of canine parvovirus B cell epitopes.
J Gen Virol. 1991 Oct;72 ( Pt 10):2445-56. doi: 10.1099/0022-1317-72-10-2445.
5
Chronic parvovirus B19 infection induces the production of anti-virus antibodies with autoantigen binding properties.慢性细小病毒B19感染诱导产生具有自身抗原结合特性的抗病毒抗体。
Eur J Immunol. 1998 Mar;28(3):936-48. doi: 10.1002/(SICI)1521-4141(199803)28:03<936::AID-IMMU936>3.0.CO;2-X.
6
A second neutralizing epitope of B19 parvovirus implicates the spike region in the immune response.细小病毒B19的第二个中和表位表明刺突区域参与免疫反应。
J Virol. 1991 Dec;65(12):7056-60. doi: 10.1128/JVI.65.12.7056-7060.1991.
7
Evaluation of a synthetic-peptide enzyme-linked immunosorbent assay for immunoglobulin M to human parvovirus B19.用于检测人细小病毒B19免疫球蛋白M的合成肽酶联免疫吸附测定法的评估
J Clin Microbiol. 1991 Jul;29(7):1376-81. doi: 10.1128/jcm.29.7.1376-1381.1991.
8
Generation of neutralizing human monoclonal antibodies against parvovirus B19 proteins.针对细小病毒B19蛋白产生中和性人单克隆抗体。
J Virol. 1999 Mar;73(3):1974-9. doi: 10.1128/JVI.73.3.1974-1979.1999.
9
Mapping of B-cell epitopes on human parvovirus B19 non-structural and structural proteins.
Vaccine. 2000 Nov 22;19(7-8):758-63. doi: 10.1016/s0264-410x(00)00258-9.
10
A cyclized peptide for studies of human parvovirus B19 infection.一种用于研究人细小病毒B19感染的环化肽。
J Immunol Methods. 1991 Apr 8;138(1):125-8. doi: 10.1016/0022-1759(91)90072-n.

引用本文的文献

1
Infectious parvovirus B19 circulates in the blood coated with active host protease inhibitors.感染性细小病毒 B19 存在于被主动宿主蛋白酶抑制剂包裹的血液中循环。
Nat Commun. 2024 Nov 5;15(1):9543. doi: 10.1038/s41467-024-53794-1.
2
Novel Surrogate Neutralizing Assay Supports Parvovirus B19 Vaccine Development for Children with Sickle Cell Disease.新型替代中和试验支持镰状细胞病患儿的B19型细小病毒疫苗研发。
Vaccines (Basel). 2021 Aug 4;9(8):860. doi: 10.3390/vaccines9080860.
3
Vaccine Design Informed by Virus-Induced Immunity.基于病毒诱导免疫的疫苗设计。
Viral Immunol. 2020 May;33(4):342-350. doi: 10.1089/vim.2019.0138. Epub 2020 May 5.
4
Parvovirus Capsid-Antibody Complex Structures Reveal Conservation of Antigenic Epitopes Across the Family.细小病毒衣壳-抗体复合物结构揭示了家族内抗原表位的保守性。
Viral Immunol. 2021 Jan-Feb;34(1):3-17. doi: 10.1089/vim.2020.0022. Epub 2020 Apr 21.
5
Advances in the Development of Antiviral Strategies against Parvovirus B19.抗细小病毒 B19 的抗病毒策略的研究进展。
Viruses. 2019 Jul 18;11(7):659. doi: 10.3390/v11070659.
6
Frequency and significance of parvovirus B19 infection in patients with rheumatoid arthritis.类风湿关节炎患者中B19微小病毒感染的频率及意义
J Gen Virol. 2016 Dec;97(12):3302-3312. doi: 10.1099/jgv.0.000621. Epub 2016 Oct 7.
7
Human Parvoviruses.人类细小病毒
Clin Microbiol Rev. 2017 Jan;30(1):43-113. doi: 10.1128/CMR.00040-16.
8
Mapping Antigenic Epitopes on the Human Bocavirus Capsid.绘制人博卡病毒衣壳上的抗原表位图谱。
J Virol. 2016 Apr 14;90(9):4670-4680. doi: 10.1128/JVI.02998-15. Print 2016 May.
9
Global co-existence of two evolutionary lineages of parvovirus B19 1a, different in genome-wide synonymous positions.球形红细胞增多症病毒 B19 1a 的两个进化谱系在全基因组同义位置上存在差异,在全球范围内共存。
PLoS One. 2012;7(8):e43206. doi: 10.1371/journal.pone.0043206. Epub 2012 Aug 13.
10
Parvovirus diagnostics and vaccine production in insect cells.细小病毒在昆虫细胞中的诊断与疫苗生产。
Cytotechnology. 1996 Jan;20(1-3):261-70. doi: 10.1007/BF00350405.

本文引用的文献

1
A simple method for displaying the hydropathic character of a protein.一种展示蛋白质亲水性特征的简单方法。
J Mol Biol. 1982 May 5;157(1):105-32. doi: 10.1016/0022-2836(82)90515-0.
2
Diagnostic assays with monoclonal antibodies for the human serum parvovirus-like virus (SPLV).用于人类血清细小病毒样病毒(SPLV)的单克隆抗体诊断检测法。
J Hyg (Lond). 1983 Aug;91(1):113-30. doi: 10.1017/s0022172400060095.
3
Infection with parvovirus-like virus and aplastic crisis in chronic hemolytic anemia.细小病毒样病毒感染与慢性溶血性贫血中的再生障碍危象
Ann Intern Med. 1983 Jun;98(6):930-2. doi: 10.7326/0003-4819-98-6-930.
4
A human parvovirus-like virus inhibits haematopoietic colony formation in vitro.一种类人细小病毒在体外抑制造血集落形成。
Nature. 1983;302(5907):426-9. doi: 10.1038/302426a0.
5
Hypothesis: the aplastic crisis of hereditary spherocytosis is due to a single transmissible agent.假说:遗传性球形红细胞增多症的再生障碍危象是由单一可传播因子引起的。
J Clin Pathol. 1983 Apr;36(4):445-8. doi: 10.1136/jcp.36.4.445.
6
Biochemical characterization of a human parvovirus.一种人细小病毒的生化特性
J Gen Virol. 1984 Jan;65 ( Pt 1):241-5. doi: 10.1099/0022-1317-65-1-241.
7
Intrauterine parvovirus infection associated with hydrops fetalis.与胎儿水肿相关的宫内细小病毒感染。
Lancet. 1984 Nov 3;2(8410):1033-4. doi: 10.1016/s0140-6736(84)91126-7.
8
Nakatani antigen and human parvovirus (B19).中谷抗原与人类细小病毒(B19)。
Lancet. 1984 Jan 21;1(8369):160-1. doi: 10.1016/s0140-6736(84)90087-4.
9
Aplastic crisis due to parvovirus infection in pyruvate kinase deficiency.丙酮酸激酶缺乏症患者因细小病毒感染引发的再生障碍危象
Lancet. 1983 Jul 2;2(8340):14-6. doi: 10.1016/s0140-6736(83)90005-3.
10
Human parvovirus, the cause of erythema infectiosum (fifth disease)?人类细小病毒,是传染性红斑(第五病)的病因吗?
Lancet. 1983 Jun 18;1(8338):1378. doi: 10.1016/s0140-6736(83)92152-9.

利用人源抗体鉴定和绘制人细小病毒B19的中和表位

Identification and mapping of neutralizing epitopes of human parvovirus B19 by using human antibodies.

作者信息

Sato H, Hirata J, Kuroda N, Shiraki H, Maeda Y, Okochi K

机构信息

Clinical Laboratory, Kyushu University Hospital, Fukuoka, Japan.

出版信息

J Virol. 1991 Oct;65(10):5485-90. doi: 10.1128/JVI.65.10.5485-5490.1991.

DOI:10.1128/JVI.65.10.5485-5490.1991
PMID:1716693
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC249042/
Abstract

We identified and mapped the regions responsible for neutralization in the human parvovirus B19 structural protein by using region-specific human antibodies derived from seropositive blood donors. The region-specific antibodies were purified by using affinity columns coupled with synthetic peptides of the hydrophilic regions including the beta-turn structure deduced by the predicted secondary structure of VP2. Fifteen highly specific antibodies against the synthetic peptides were obtained. Ten of them were able to precipitate the radiolabeled virus. Six of them proved to be able to protect the colony-forming unit erythroid cells in human bone marrow cell cultures from injury by the virus. The sequences recognized by the six neutralizing antibodies were sites corresponding to amino acids 253 to 272, 309 to 330, 325 to 346, 359 to 382, 449 to 468, and 491 to 515 from the amino-terminal portion of VP2. These observations suggest that the neutralizing epitopes were distributed in the region from amino acid 253 in the amino-terminal portion of VP2 to the carboxyl terminus of VP2.

摘要

我们通过使用来自血清反应阳性献血者的区域特异性人抗体,鉴定并绘制了人细小病毒B19结构蛋白中负责中和作用的区域。通过使用与亲水区合成肽偶联的亲和柱纯化区域特异性抗体,所述亲水区包括由VP2预测二级结构推导的β-转角结构。获得了15种针对合成肽的高特异性抗体。其中10种能够沉淀放射性标记病毒。其中6种被证明能够保护人骨髓细胞培养物中的集落形成单位红细胞免受病毒损伤。这6种中和抗体识别的序列是与VP2氨基末端部分的氨基酸253至272、309至330、325至346、359至382、449至468以及491至515相对应的位点。这些观察结果表明,中和表位分布在从VP2氨基末端部分的氨基酸253到VP2羧基末端的区域。